Thinq Pharma-Cro Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 03-07-2024
- Paid Up Capital ₹ 0.50 M
as on 03-07-2024
- Company Age 18 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 127.63 Cr
as on 03-07-2024
- Satisfied Charges ₹ 16.75 Cr
as on 03-07-2024
- Revenue -4.50%
(FY 2023)
- Profit 6.88%
(FY 2023)
- Ebitda 18.66%
(FY 2023)
- Net Worth 33.72%
(FY 2023)
- Total Assets 7.16%
(FY 2023)
About Thinq Pharma-Cro
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹127.63 Cr. The company has closed loans amounting to ₹16.75 Cr, as per Ministry of Corporate Affairs (MCA) records.
Chandrashekhar Nadkarni, Ravindra Gulgule, Rohit Gulgule, and One other member serve as directors at the Company.
- CIN/LLPIN
U24239MH2006PLC165473
- Company No.
165473
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
10 Nov 2006
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Thinq Pharma-Cro Limited offer?
Thinq Pharma-Cro Limited offers a wide range of products and services, including Ayurvedic,Herbal Products & Medicine, Honey & Sweeteners, Fitness Supplements, BCAA Powder, Weight Gain Nutrition, Lean Mass Gainer, Health Supplement.
Who are the key members and board of directors at Thinq Pharma-Cro?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chandrashekhar Nadkarni  | Managing Director | 10-Nov-2006 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ravindra Gulgule | Director | 15-Sep-2011 | Current |
| Rohit Gulgule | Director | 10-Nov-2006 | Current |
| Shibani Nadkarni | Director | 10-Nov-2006 | Current |
Financial Performance of Thinq Pharma-Cro.
Thinq Pharma-Cro Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 4.5% decrease. The company also saw a slight improvement in profitability, with a 6.88% increase in profit. The company's net worth Soared by an impressive increase of 33.72%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Thinq Pharma-Cro?
In 2023, Thinq Pharma-Cro had a promoter holding of 96.00% and a public holding of 4.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Hongkong And Shanghai Banking Corporation Limited Creation Date: 29 Aug 2022 | ₹20.00 Cr | Open |
Hdfc Bank Limited Creation Date: 23 Nov 2020 | ₹8.20 Cr | Open |
Hdfc Bank Limited Creation Date: 02 Jan 2018 | ₹12.00 Cr | Open |
How Many Employees Work at Thinq Pharma-Cro?
Thinq Pharma-Cro has a workforce of 141 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Thinq Pharma-Cro, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Thinq Pharma-Cro's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
